Insight in Germany

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

Click here to sort results by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Report
Report

Pipeline and Commercial Insight: Psoriasis - Established brands challenged by new therapies

Overview of the current and future psoriasis market, providing in-depth analysis of recent events in the market together with 10 year indication specific sales forecasts and profiles of key brands and pipeline products across the seven major markets.

Published By Datamonitor
10 Dec 2010 $15200
Buy
Report
Report

Pipeline and Commercial Insight: Urinary Incontinence - Marketing investment and niche positioning are key strategies for success

Full analysis of the future urinary incontinence market. Includes sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) for key marketed brands, generics, and pipeline products.

Published By Datamonitor
15 Dec 2010 $15200
Buy
Report
Report

Private Label Food and Non-Alcoholic Drink Trends: Post-Downturn Implications and Opportunities

Explores in detail the consumer, product and market trends in food and non-alcoholic beverage private label brand purchases. It covers shoppers' deepening desire for value and their relative attachment to manufacturer versus private label brands.

Published By Datamonitor
11 Jan 2011 $3450
Buy

Logging On: Making the Most of the Online Channel - Save 30%

To take advantage of this offer enter Promo Code CWKF18 when prompted in the checkout

More information

Report
Report

Logging On: Online and Mobile Channels in Global Financial Services

This report is the second in the global customer experience series, and focuses on the online channel. It assesses the current state of online and mobile banking provision across the world, and discusses likely future developments.

Published By Datamonitor
21 Jan 2011 $5250
Buy
Report
Report

Food & Alcohol Pairing: Consumer Occasions and Marketing Opportunities

This report looks at the multifaceted issues of food and alcohol pairings and how CPG manufactures in both the food and alcohol sectors can capitalize on this opportunity.

Published By Datamonitor
21 Jan 2011 $3450
Buy
Report
Report

Private Label Household Care Trends: Post-Downturn Implications & Opportunities

Explores in detail the consumer, product and market trends in household care private label brand purchases. It covers shoppers' deepening desire for value and their relative attachment to manufacturer versus private label brands.

Published By Datamonitor
31 Jan 2011 $3450
Buy

Private Label Alcoholic Beverage Trends - SAVE 15%

To take advantage of this offer enter Promo Code ALCO15 when prompted in the checkout

More information

Report
Report

Private Label Alcoholic Beverage Trends: Post-Downturn Implications and Opportunities

Explores in detail the consumer, product and market trends in alcoholic beverage private label brand purchases. It covers shoppers' deepening desire for value and their relative attachment to manufacturer versus private label brands.

Published By Datamonitor
09 Feb 2011 $3450
Buy
Report
Report

Private Label Trends in Personal Care: Post-Downturn Implications & Opportunities

Explores in detail the consumer, product and market trends in personal care private label brand purchases. It covers shoppers' deepening desire for value and their relative attachment to manufacturer versus private label brands

Published By Datamonitor
28 Feb 2011 $3450
Buy
Brief
Brief

InReview: Retail Logistics in Germany

The report provides comprehensive information and analysis about the characteristics of logistics spend in the German retail industry. It also highlights the areas of improvement for logistics providers catering to the German retail market.

Published By Datamonitor
29 Apr 2011 $1495
Buy
Report
Report

Product Profiles: Allergic Rhinitis - Heavily genericized market sees areas of innovation

Allergic rhinitis is an established, yet dynamic market. The April 2011 FDA filing of Dymista (azelastine/fluticasone; Meda/Cipla) could bring a new class to the market, while efforts to retain brand share have been seen in monotherapy classes.

Published By Datamonitor
23 Jun 2011 $11400
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

No help is available.